Neurovascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034
Description
Neurovascular Devices Market Summary
This neurovascular devices market report offers a comprehensive overview of the global neurovascular devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Cerebral Embolization and Aneurysm Coiling Devices [Embolic Coils, Flow Diversion Devices, and Liquid Embolic Agents], Cerebral Balloon Angioplasty and Stenting Systems [Carotid Artery Stents and Embolic Protection Systems], Neurothrombectomy Devices [Clot Retrievers, Suction Devices, and Vascular Snare], and Support Devices [Micro Catheters and Micro Guidewires]), Application (Stroke, Cerebral Aneurysm, Carotid Artery Stenosis, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing neurovascular devices market.
Neurovascular devices are specialized medical devices used to diagnose and treat disorders affecting the blood vessels of the brain and spinal cord. These devices are primarily used in minimally invasive procedures to manage conditions such as stroke, cerebral aneurysms, arteriovenous malformations (AVMs), and other cerebrovascular diseases. Common examples include stent retrievers, flow diverters, embolization coils, thrombectomy devices, and microcatheters, which help restore blood flow, prevent vessel rupture, or block abnormal blood vessels in the brain.
The neurovascular devices market is being primarily driven by the rising prevalence of neurological disorders such as stroke, cerebral aneurysms, arteriovenous malformations, and other cerebrovascular diseases. The increasing incidence of ischemic and hemorrhagic strokes, particularly among the aging population and individuals with risk factors like hypertension and diabetes, is significantly boosting the demand for advanced neurovascular intervention devices. Additionally, growing awareness about early diagnosis, advancements in minimally invasive procedures, and improved healthcare infrastructure are further accelerating the adoption of neurovascular devices across hospitals and specialty neurology centers.
Get More Insights into the Report @Neurovascular Devices Market
What are the latest neurovascular devices market dynamics and trends?
The Neurovascular Devices Market is gaining pace at present, owing to the increasing prevalence of Neurovascular diseases and their associated comorbidities such as ischemic strokes, hemorrhagic strokes, aging populations, hypertension, and arrhythmias.
According to recent analysis by DelveInsight, the 7MM (United States, Japan, Germany, France, Italy, Spain, and the United Kingdom) accounted for over 1.5 million cases of acute ischemic stroke. Globally, it is estimated that more than 3.5 million new cases of intracerebral hemorrhagic stroke occur each year, representing over 28.5% of all stroke incidents. In addition, approximately 1.3 million new subarachnoid hemorrhagic strokes are reported annually. Notably, a significant proportion of these cases, over 23.1% of intracerebral hemorrhagic strokes and 28% of subarachnoid hemorrhagic strokes, affect individuals aged 15-49, highlighting the impact on a younger population and the critical need for timely interventions.
These statistics directly translate to increased adoption of Neurovascular devices such as stent retrievers, embolic coils, flow diverters, and carotid stents, which are essential for minimally invasive management of ischemic and hemorrhagic strokes. As stroke awareness among clinicians and patients rises, the push for early diagnosis and intervention grows stronger, further driving demand for advanced, precise, and safe devices. Moreover, technological advancements in imaging, device design, and materials enhance procedural success and reduce complications, making these interventions more attractive to hospitals and healthcare providers. This combination of high patient burden, clinical need for effective treatment, and continuous innovation in device technology is creating a strong growth trajectory for the Neurovascular devices market.
The players are focusing their efforts on developing advanced Neurovascular devices. For instance, in June 2024, Penumbra announced the CE Mark and European launch of BMX™81 and BMX™96. These offerings, designed for the Neurovascular management of both ischemic and hemorrhagic strokes, represent Penumbra’s most advanced neuro access technologies to date, reflecting the emphasis on innovation and clinical efficacy in the neurovascular devices market.
Thus, the factors mentioned above are expected to boost the overall market of neurovascular devices during the forecast period from 2026 to 2034.
However, the growing number of product recalls, particularly those related to safety concerns, device malfunctions, or quality control issues, is expected to negatively impact the future growth of the neurovascular devices market. Recalls not only result in financial losses for manufacturers due to product withdrawals, legal liabilities, and corrective actions, but they also damage brand reputation and reduce physician and patient confidence in advanced neurovascular technologies. In addition, the stringent regulatory approval processes imposed by authorities such as the FDA and EMA further act as a limiting factor for market expansion. Neurovascular devices, being high-risk and life-saving products used in conditions such as stroke and aneurysm, must undergo extensive clinical trials, rigorous safety evaluations, and detailed documentation before receiving approval. These requirements significantly increase development timelines and costs, delaying product launches and limiting the entry of new players into the market. As a result, while innovation in neurovascular devices continues to advance, regulatory complexities and recall-related challenges may restrain the overall growth potential of the market in the coming years.
Neurovascular Devices Market Segment Analysis
Neurovascular Devices Market by Product Type (Cerebral Embolization and Aneurysm Coiling Devices [Embolic Coils, Flow Diversion Devices, and Liquid Embolic Agents], Cerebral Balloon Angioplasty and Stenting Systems [Carotid Artery Stents and Embolic Protection Systems], Neurothrombectomy Devices [Clot Retrievers, Suction Devices, and Vascular Snare], and Support Devices [Micro Catheters and Micro Guidewires]), Application (Stroke, Cerebral Aneurysm, Carotid Artery Stenosis, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
Neurovascular Devices Market Regional Analysis
North America Neurovascular Devices Market Trends
North America is expected to account for the highest proportion of 38% of the neurovascular devices market in 2025, out of all regions, due to the high prevalence of stroke and other neurovascular disorders, a well-established healthcare infrastructure, strong adoption of advanced and minimally invasive technologies, and supportive reimbursement policies. Additionally, the presence of leading medical device companies, continuous R&D investments, and growing awareness programs for stroke prevention and treatment further strengthen the region’s market leadership.
According to DelveInsight analysis (2023), approximately 376,000 males and 378,000 females in the United States were affected by acute ischemic stroke in 2023. This significant patient population is driving strong demand for advanced neurovascular devices, including thrombectomy systems, embolic protection devices, clot retrieval catheters, and stent retrievers, as hospitals and healthcare providers seek to improve patient outcomes and reduce mortality rates.
Furthermore, the growing adoption of advanced and minimally invasive technologies is further accelerating the Neurovascular devices market. Procedures such as thrombectomy and endovascular coiling have become standard practice due to their ability to deliver favorable outcomes, lower complication rates, and shorter recovery times. In addition, increasing product development activities by key market players are expected to further boost neurovascular devices market growth. For example, in October 2024, Contego Medical received FDA premarket approval (PMA) for the Neuroguard IEP® System, featuring the company’s clinically proven Integrated Embolic Protection™ (IEP) technology, highlighting the ongoing innovation and expansion in the neuroprotection devices segment.
Therefore, the factors mentioned above are expected to drive the growth of the neurovascular devices market in North America.
Europe Neurovascular Devices Market Trends
Europe is playing a significant role in driving the growth of Neurovascular devices fueled The region has a high prevalence of Neurovascular disorders, including acute ischemic stroke, aneurysms, and arteriovenous malformations, which creates a substantial demand for advanced treatment options. European healthcare systems are increasingly focusing on early diagnosis and minimally invasive interventions, which has accelerated the adoption of Neurovascular devices such as thrombectomy systems, embolic protection devices, stent retrievers, and clot retrieval catheters. Moreover, the presence of key market players and continuous product innovation in the region, such as the development of next-generation thrombectomy and embolic protection devices, further strengthens market expansion. For instance, in June 2025, InspireMD announced that its CGuard® Prime Embolic Prevention System (EPS) received CE Mark approval under the European Medical Device Regulation (MDR) for use in stroke prevention.
Thus, the factors mentioned above are expected to boost the overall market of neurovascular devices in the Europe.
Asia-Pacific Neurovascular Devices Market Trends
Asia-Pacific is emerging as a major growth driver for the Neurovascular devices market due to its rapidly rising patient pool for Neurovascular disorders, including acute ischemic stroke and aneurysms, driven by aging populations. DelveInsight estimates indicated that in Japan, males were affected more with acute ischemic stroke, accounting for nearly 100,000 cases compared to females (around 90,000 cases) in 2023. Additionally, the growing awareness about early diagnosis and the benefits of minimally invasive procedures is fueling the adoption of advanced Neurovascular devices, including thrombectomy systems, stent retrievers, and embolic protection devices across the region.
Thus, the factors mentioned above are expected to boost the overall market of neurovascular devices in the Asia-Pacific region.
Who are the major players in the neurovascular devices market?
The following are the leading companies in the neurovascular devices market. These companies collectively hold the largest market share and dictate industry trends.
The competitive landscape of the neurovascular devices market is moderately consolidated, with a handful of global leaders holding substantial market share while regional players and emerging startups are steadily gaining traction. Major Neurovascular devices companies such as Medtronic, Stryker Corporation, Johnson & Johnson, Penumbra Inc., and Terumo Corporation dominate the market with comprehensive portfolios of neurovascular stents, coils, thrombectomy devices, and embolization systems, supported by advanced technologies and extensive global distribution networks. These companies are strengthening their positions through continuous innovation in minimally invasive procedures, integration of imaging and navigation technologies, and strategic acquisitions, exemplified by Stryker’s acquisition of Inari Medical to expand its Neurovascular offerings. At the same time, emerging players, particularly in Asia-Pacific regions like China, Japan, and India, are intensifying competition by providing cost-effective devices and localized solutions, aiming to address the growing prevalence of strokes and other cerebrovascular disorders. The increasing focus on portable, efficient, and user-friendly neurovascular interventions, coupled with rising adoption in hospitals and specialized clinics, is opening avenues for new entrants. Overall, while the market remains concentrated among established leaders, the rise of regional innovators and strategic collaborations is gradually reshaping the competitive environment, making it more dynamic and innovation-driven.
Recent Developmental Activities in the Neurovascular Devices Market
Cerebral Aneurysm
Carotid Artery Stenosis
Others
Ambulatory Surgical Centers
Others
AI-Powered Innovations and Applications:
Artificial intelligence (AI) is rapidly transforming the Neurovascular devices market by enhancing the accuracy, efficiency, and safety of cerebrovascular diagnosis and interventions. AI-powered tools are increasingly integrated into imaging platforms, enabling real-time analysis of complex Neurovascular structures through high-resolution MRI, CT, and angiography. These technologies assist clinicians in identifying vascular anomalies, planning interventions, and predicting procedural outcomes with higher precision. Machine learning algorithms also support stroke detection by rapidly analyzing imaging data to distinguish between ischemic and hemorrhagic strokes, which accelerates decision-making in critical care settings. Beyond diagnostics, AI is being applied in robotic-assisted Neurovascular interventions, guiding catheters, stents, and thrombectomy devices with improved precision and reduced procedural risks. Additionally, AI-driven platforms facilitate personalized treatment planning by integrating patient-specific anatomical and physiological data, optimizing device selection, and predicting clinical outcomes. The incorporation of cloud-based monitoring, predictive analytics, and decision-support systems further enhances post-procedural care and follow-up, improving overall patient outcomes. Overall, AI-powered innovations are redefining Neurovascular care, enabling minimally invasive procedures, enhancing procedural safety, and paving the way for more personalized and efficient treatment strategies.
U.S. Tariff Impact Analysis on Neurovascular Devices Market:
The U.S. tariff impact on the neurovascular devices market is an important consideration for manufacturers, healthcare providers, and distributors, as tariffs on imported raw materials or finished components can increase production and procurement costs. Neurovascular devices, which include high-precision products such as thrombectomy systems, embolization coils, stents, and flow diverters, often rely on specialized metals, polymers, and electronic components sourced globally. When tariffs are imposed on these imports whether through broader trade policy shifts, anti-dumping measures, or changes in U.S. Customs duties manufacturers may experience higher input costs, which can compress profit margins or be passed downstream in the form of higher prices for healthcare providers and patients. Additionally, tariffs can strain global supply chains, leading to delays and logistical challenges that further elevate operational costs. For U.S.-based companies that export neurovascular devices, retaliatory tariffs in foreign markets can reduce price competitiveness and market share internationally. Together, these factors can slow investment, influence strategic manufacturing decisions (such as reshoring or sourcing diversification), and potentially hinder the overall growth trajectory of the neurovascular devices market in the United States. Effective tariff impact analysis therefore remains critical for stakeholders to anticipate cost pressures, optimize supply chain resilience, and navigate evolving trade environments.
How This Analysis Helps Clients
1. What is the growth rate of the neurovascular devices market?
- The global neurovascular devices market is expected to increase from USD 3,904.74 million in 2025 to USD 8,044.66 million by 2034, reflecting strong and sustained growth.
- The global neurovascular devices market is growing at a CAGR of 8.40% during the forecast period from 2026 to 2034.
- The neurovascular devices market is being primarily driven by the rising prevalence of neurological disorders such as stroke, cerebral aneurysms, arteriovenous malformations, and other cerebrovascular diseases. The increasing incidence of ischemic and hemorrhagic strokes, particularly among the aging population and individuals with risk factors like hypertension and diabetes, is significantly boosting the demand for advanced neurovascular intervention devices. Additionally, growing awareness about early diagnosis, advancements in minimally invasive procedures, and improved healthcare infrastructure are further accelerating the adoption of neurovascular devices across hospitals and specialty neurology centers.
- The leading companies operating in the neurovascular devices market include Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, Cerus Endovascular Inc., and others.
- North America is expected to dominate the overall neurovascular devices market due to the high prevalence of stroke and other neurovascular disorders, a well-established healthcare infrastructure, strong adoption of advanced and minimally invasive technologies, and supportive reimbursement policies. Additionally, the presence of leading medical device companies, continuous R&D investments, and growing awareness programs for stroke prevention and treatment further strengthen the region’s market leadership.
- In the product segment of the neurovascular devices market, within cerebral balloon angioplasty and stenting systems category, the carotid artery stents category is estimated to account for the largest market share in 2025.
- Increasing prevalence of neurological disorders leading to a surge in neurovascular devices: The increasing prevalence of neurological disorders such as stroke, brain aneurysms, and arteriovenous malformations is a key factor boosting the overall market for neurovascular devices. Rising cases of these conditions, driven by aging populations, sedentary lifestyles, and associated risk factors like hypertension and diabetes, are creating higher demand for advanced diagnostic and treatment solutions. This is accelerating the adoption of neurovascular devices for minimally invasive procedures, thereby fueling market growth.
- Increasing technological advancements in devices are escalating the market of neurovascular devices: Increasing technological advancements in neurovascular devices, such as next-generation stent retrievers, flow diverters, embolic coils, and AI-enabled imaging systems, are significantly escalating the market. These innovations enhance precision, safety, and success rates of minimally invasive procedures, reducing recovery time and complications. As a result, hospitals and clinicians are increasingly adopting these advanced solutions, driving strong neurovascular devices market growth.
- Increase in product development activities among the key market players: The increase in product development activities among key market players is significantly boosting the neurovascular devices market by introducing more advanced, safer, and minimally invasive treatment options. Companies are continuously innovating and launching next-generation thrombectomy devices, flow diverters, embolization coils, and stent retrievers that improve procedural success rates and reduce complications. These advancements enhance treatment precision for conditions such as stroke and cerebral aneurysms, encouraging greater adoption among neurosurgeons and interventional radiologists. As a result, continuous R&D investments and new product approvals are accelerating market growth and strengthening competitive dynamics in the neurovascular devices sector.
This neurovascular devices market report offers a comprehensive overview of the global neurovascular devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Cerebral Embolization and Aneurysm Coiling Devices [Embolic Coils, Flow Diversion Devices, and Liquid Embolic Agents], Cerebral Balloon Angioplasty and Stenting Systems [Carotid Artery Stents and Embolic Protection Systems], Neurothrombectomy Devices [Clot Retrievers, Suction Devices, and Vascular Snare], and Support Devices [Micro Catheters and Micro Guidewires]), Application (Stroke, Cerebral Aneurysm, Carotid Artery Stenosis, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing neurovascular devices market.
Neurovascular devices are specialized medical devices used to diagnose and treat disorders affecting the blood vessels of the brain and spinal cord. These devices are primarily used in minimally invasive procedures to manage conditions such as stroke, cerebral aneurysms, arteriovenous malformations (AVMs), and other cerebrovascular diseases. Common examples include stent retrievers, flow diverters, embolization coils, thrombectomy devices, and microcatheters, which help restore blood flow, prevent vessel rupture, or block abnormal blood vessels in the brain.
The neurovascular devices market is being primarily driven by the rising prevalence of neurological disorders such as stroke, cerebral aneurysms, arteriovenous malformations, and other cerebrovascular diseases. The increasing incidence of ischemic and hemorrhagic strokes, particularly among the aging population and individuals with risk factors like hypertension and diabetes, is significantly boosting the demand for advanced neurovascular intervention devices. Additionally, growing awareness about early diagnosis, advancements in minimally invasive procedures, and improved healthcare infrastructure are further accelerating the adoption of neurovascular devices across hospitals and specialty neurology centers.
Get More Insights into the Report @Neurovascular Devices Market
What are the latest neurovascular devices market dynamics and trends?
The Neurovascular Devices Market is gaining pace at present, owing to the increasing prevalence of Neurovascular diseases and their associated comorbidities such as ischemic strokes, hemorrhagic strokes, aging populations, hypertension, and arrhythmias.
According to recent analysis by DelveInsight, the 7MM (United States, Japan, Germany, France, Italy, Spain, and the United Kingdom) accounted for over 1.5 million cases of acute ischemic stroke. Globally, it is estimated that more than 3.5 million new cases of intracerebral hemorrhagic stroke occur each year, representing over 28.5% of all stroke incidents. In addition, approximately 1.3 million new subarachnoid hemorrhagic strokes are reported annually. Notably, a significant proportion of these cases, over 23.1% of intracerebral hemorrhagic strokes and 28% of subarachnoid hemorrhagic strokes, affect individuals aged 15-49, highlighting the impact on a younger population and the critical need for timely interventions.
These statistics directly translate to increased adoption of Neurovascular devices such as stent retrievers, embolic coils, flow diverters, and carotid stents, which are essential for minimally invasive management of ischemic and hemorrhagic strokes. As stroke awareness among clinicians and patients rises, the push for early diagnosis and intervention grows stronger, further driving demand for advanced, precise, and safe devices. Moreover, technological advancements in imaging, device design, and materials enhance procedural success and reduce complications, making these interventions more attractive to hospitals and healthcare providers. This combination of high patient burden, clinical need for effective treatment, and continuous innovation in device technology is creating a strong growth trajectory for the Neurovascular devices market.
The players are focusing their efforts on developing advanced Neurovascular devices. For instance, in June 2024, Penumbra announced the CE Mark and European launch of BMX™81 and BMX™96. These offerings, designed for the Neurovascular management of both ischemic and hemorrhagic strokes, represent Penumbra’s most advanced neuro access technologies to date, reflecting the emphasis on innovation and clinical efficacy in the neurovascular devices market.
Thus, the factors mentioned above are expected to boost the overall market of neurovascular devices during the forecast period from 2026 to 2034.
However, the growing number of product recalls, particularly those related to safety concerns, device malfunctions, or quality control issues, is expected to negatively impact the future growth of the neurovascular devices market. Recalls not only result in financial losses for manufacturers due to product withdrawals, legal liabilities, and corrective actions, but they also damage brand reputation and reduce physician and patient confidence in advanced neurovascular technologies. In addition, the stringent regulatory approval processes imposed by authorities such as the FDA and EMA further act as a limiting factor for market expansion. Neurovascular devices, being high-risk and life-saving products used in conditions such as stroke and aneurysm, must undergo extensive clinical trials, rigorous safety evaluations, and detailed documentation before receiving approval. These requirements significantly increase development timelines and costs, delaying product launches and limiting the entry of new players into the market. As a result, while innovation in neurovascular devices continues to advance, regulatory complexities and recall-related challenges may restrain the overall growth potential of the market in the coming years.
Neurovascular Devices Market Segment Analysis
Neurovascular Devices Market by Product Type (Cerebral Embolization and Aneurysm Coiling Devices [Embolic Coils, Flow Diversion Devices, and Liquid Embolic Agents], Cerebral Balloon Angioplasty and Stenting Systems [Carotid Artery Stents and Embolic Protection Systems], Neurothrombectomy Devices [Clot Retrievers, Suction Devices, and Vascular Snare], and Support Devices [Micro Catheters and Micro Guidewires]), Application (Stroke, Cerebral Aneurysm, Carotid Artery Stenosis, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
Neurovascular Devices Market Regional Analysis
North America Neurovascular Devices Market Trends
North America is expected to account for the highest proportion of 38% of the neurovascular devices market in 2025, out of all regions, due to the high prevalence of stroke and other neurovascular disorders, a well-established healthcare infrastructure, strong adoption of advanced and minimally invasive technologies, and supportive reimbursement policies. Additionally, the presence of leading medical device companies, continuous R&D investments, and growing awareness programs for stroke prevention and treatment further strengthen the region’s market leadership.
According to DelveInsight analysis (2023), approximately 376,000 males and 378,000 females in the United States were affected by acute ischemic stroke in 2023. This significant patient population is driving strong demand for advanced neurovascular devices, including thrombectomy systems, embolic protection devices, clot retrieval catheters, and stent retrievers, as hospitals and healthcare providers seek to improve patient outcomes and reduce mortality rates.
Furthermore, the growing adoption of advanced and minimally invasive technologies is further accelerating the Neurovascular devices market. Procedures such as thrombectomy and endovascular coiling have become standard practice due to their ability to deliver favorable outcomes, lower complication rates, and shorter recovery times. In addition, increasing product development activities by key market players are expected to further boost neurovascular devices market growth. For example, in October 2024, Contego Medical received FDA premarket approval (PMA) for the Neuroguard IEP® System, featuring the company’s clinically proven Integrated Embolic Protection™ (IEP) technology, highlighting the ongoing innovation and expansion in the neuroprotection devices segment.
Therefore, the factors mentioned above are expected to drive the growth of the neurovascular devices market in North America.
Europe Neurovascular Devices Market Trends
Europe is playing a significant role in driving the growth of Neurovascular devices fueled The region has a high prevalence of Neurovascular disorders, including acute ischemic stroke, aneurysms, and arteriovenous malformations, which creates a substantial demand for advanced treatment options. European healthcare systems are increasingly focusing on early diagnosis and minimally invasive interventions, which has accelerated the adoption of Neurovascular devices such as thrombectomy systems, embolic protection devices, stent retrievers, and clot retrieval catheters. Moreover, the presence of key market players and continuous product innovation in the region, such as the development of next-generation thrombectomy and embolic protection devices, further strengthens market expansion. For instance, in June 2025, InspireMD announced that its CGuard® Prime Embolic Prevention System (EPS) received CE Mark approval under the European Medical Device Regulation (MDR) for use in stroke prevention.
Thus, the factors mentioned above are expected to boost the overall market of neurovascular devices in the Europe.
Asia-Pacific Neurovascular Devices Market Trends
Asia-Pacific is emerging as a major growth driver for the Neurovascular devices market due to its rapidly rising patient pool for Neurovascular disorders, including acute ischemic stroke and aneurysms, driven by aging populations. DelveInsight estimates indicated that in Japan, males were affected more with acute ischemic stroke, accounting for nearly 100,000 cases compared to females (around 90,000 cases) in 2023. Additionally, the growing awareness about early diagnosis and the benefits of minimally invasive procedures is fueling the adoption of advanced Neurovascular devices, including thrombectomy systems, stent retrievers, and embolic protection devices across the region.
Thus, the factors mentioned above are expected to boost the overall market of neurovascular devices in the Asia-Pacific region.
Who are the major players in the neurovascular devices market?
The following are the leading companies in the neurovascular devices market. These companies collectively hold the largest market share and dictate industry trends.
- Johnson & Johnson Services Inc.
- Medtronic
- Stryker
- Terumo Corporation
- Penumbra, Inc.
- Microport Scientific Corporation
- Kaneka Corporation
- Integer Holdings Corporation
- phenox GmbH
- Perflow Medical Ltd.
- Balt
- Rapid Medical
- ASAHI INTECC CO., LTD.
- Acandis GmbH
- Cerus Endovascular Inc.
- Others
The competitive landscape of the neurovascular devices market is moderately consolidated, with a handful of global leaders holding substantial market share while regional players and emerging startups are steadily gaining traction. Major Neurovascular devices companies such as Medtronic, Stryker Corporation, Johnson & Johnson, Penumbra Inc., and Terumo Corporation dominate the market with comprehensive portfolios of neurovascular stents, coils, thrombectomy devices, and embolization systems, supported by advanced technologies and extensive global distribution networks. These companies are strengthening their positions through continuous innovation in minimally invasive procedures, integration of imaging and navigation technologies, and strategic acquisitions, exemplified by Stryker’s acquisition of Inari Medical to expand its Neurovascular offerings. At the same time, emerging players, particularly in Asia-Pacific regions like China, Japan, and India, are intensifying competition by providing cost-effective devices and localized solutions, aiming to address the growing prevalence of strokes and other cerebrovascular disorders. The increasing focus on portable, efficient, and user-friendly neurovascular interventions, coupled with rising adoption in hospitals and specialized clinics, is opening avenues for new entrants. Overall, while the market remains concentrated among established leaders, the rise of regional innovators and strategic collaborations is gradually reshaping the competitive environment, making it more dynamic and innovation-driven.
Recent Developmental Activities in the Neurovascular Devices Market
- In May 2025, Terumo Interventional Systems announced the commercial launch of its FDA-approved ROADSAVER™ Carotid Stent System. Designed for use with the Nanoparasol® Embolic Protection System, the ROADSAVER Stent System is intended to treat carotid artery stenosis in patients at elevated risk of complications from carotid endarterectomy.
- In March 2025, Boston Scientific launched an updated FilterWire EZ embolic protection system in select European markets. The system features a wire with a 110-micron-pore filter at its tip, designed to capture embolic material while maintaining blood flow and reliably conforming to the artery walls.
- Neurovascular Devices by Product Type Exposure
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Carotid Artery Stents
- Embolic Protection Systems
- Clot Retrievers
- Suction Devices
- Vascular Snare
- Micro Catheters
- Micro Guidewires
- Neurovascular Devices Application Exposure
Cerebral Aneurysm
Carotid Artery Stenosis
Others
- Neurovascular Devices End-Users Exposure
Ambulatory Surgical Centers
Others
- Neurovascular Devices Geography Exposure
- United States Neurovascular Devices Market
- Canada Neurovascular Devices Market
- Mexico Neurovascular Devices Market
- United Kingdom Neurovascular Devices Market
- Germany Neurovascular Devices Market
- France Neurovascular Devices Market
- Italy Neurovascular Devices Market
- Spain Neurovascular Devices Market
- Rest of Europe Neurovascular Devices Market
- China Neurovascular Devices Market
- Japan Neurovascular Devices Market
- India Neurovascular Devices Market
- Australia Neurovascular Devices Market
- South Korea Neurovascular Devices Market
- Rest of Asia-Pacific Neurovascular Devices Market
- South America Neurovascular Devices Market
- Middle East Neurovascular Devices Market
- Africa Neurovascular Devices Market
AI-Powered Innovations and Applications:
Artificial intelligence (AI) is rapidly transforming the Neurovascular devices market by enhancing the accuracy, efficiency, and safety of cerebrovascular diagnosis and interventions. AI-powered tools are increasingly integrated into imaging platforms, enabling real-time analysis of complex Neurovascular structures through high-resolution MRI, CT, and angiography. These technologies assist clinicians in identifying vascular anomalies, planning interventions, and predicting procedural outcomes with higher precision. Machine learning algorithms also support stroke detection by rapidly analyzing imaging data to distinguish between ischemic and hemorrhagic strokes, which accelerates decision-making in critical care settings. Beyond diagnostics, AI is being applied in robotic-assisted Neurovascular interventions, guiding catheters, stents, and thrombectomy devices with improved precision and reduced procedural risks. Additionally, AI-driven platforms facilitate personalized treatment planning by integrating patient-specific anatomical and physiological data, optimizing device selection, and predicting clinical outcomes. The incorporation of cloud-based monitoring, predictive analytics, and decision-support systems further enhances post-procedural care and follow-up, improving overall patient outcomes. Overall, AI-powered innovations are redefining Neurovascular care, enabling minimally invasive procedures, enhancing procedural safety, and paving the way for more personalized and efficient treatment strategies.
U.S. Tariff Impact Analysis on Neurovascular Devices Market:
The U.S. tariff impact on the neurovascular devices market is an important consideration for manufacturers, healthcare providers, and distributors, as tariffs on imported raw materials or finished components can increase production and procurement costs. Neurovascular devices, which include high-precision products such as thrombectomy systems, embolization coils, stents, and flow diverters, often rely on specialized metals, polymers, and electronic components sourced globally. When tariffs are imposed on these imports whether through broader trade policy shifts, anti-dumping measures, or changes in U.S. Customs duties manufacturers may experience higher input costs, which can compress profit margins or be passed downstream in the form of higher prices for healthcare providers and patients. Additionally, tariffs can strain global supply chains, leading to delays and logistical challenges that further elevate operational costs. For U.S.-based companies that export neurovascular devices, retaliatory tariffs in foreign markets can reduce price competitiveness and market share internationally. Together, these factors can slow investment, influence strategic manufacturing decisions (such as reshoring or sourcing diversification), and potentially hinder the overall growth trajectory of the neurovascular devices market in the United States. Effective tariff impact analysis therefore remains critical for stakeholders to anticipate cost pressures, optimize supply chain resilience, and navigate evolving trade environments.
How This Analysis Helps Clients
- Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
- Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
- Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
- Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.
- Market size analysis for the current neurovascular devices market size (2025), and market forecast for 8 years (2026 to 2034)
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
- Key companies dominating the neurovascular devices market.
- Various opportunities available for the other competitors in the neurovascular devices market space.
- What are the top-performing segments in 2025? How these segments will perform in 2034?
- Which are the top-performing regions and countries in the current neurovascular devices market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for the neurovascular devices market growth in the future?
1. What is the growth rate of the neurovascular devices market?
- The neurovascular devices market is estimated to grow at a CAGR of 8.40% during the forecast period from 2026 to 2034.
- The global neurovascular devices market is expected to increase from USD 3,904.74 million in 2025 to USD 8,044.66 million by 2034, reflecting strong and sustained growth.
- North America is expected to dominate the overall neurovascular devices market due to the high prevalence of stroke and other neurovascular disorders, a well-established healthcare infrastructure, strong adoption of advanced and minimally invasive technologies, and supportive reimbursement policies. Additionally, the presence of leading medical device companies, continuous R&D investments, and growing awareness programs for stroke prevention and treatment further strengthen the region’s market leadership.
- The neurovascular devices market is being primarily driven by the rising prevalence of neurological disorders such as stroke, cerebral aneurysms, arteriovenous malformations, and other cerebrovascular diseases. The increasing incidence of ischemic and hemorrhagic strokes, particularly among the aging population and individuals with risk factors like hypertension and diabetes, is significantly boosting the demand for advanced neurovascular intervention devices. Additionally, growing awareness about early diagnosis, advancements in minimally invasive procedures, and improved healthcare infrastructure are further accelerating the adoption of neurovascular devices across hospitals and specialty neurology centers.
- Some of the key market players operating in the neurovascular devices market include Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, Cerus Endovascular Inc., and others.
Table of Contents
150 Pages
- 1. Neurovascular Devices Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumption
- 2. Neurovascular Devices Market Executive Summary
- 2.1 Market at Glance
- 3. Neurovascular Devices Market Key Factors Analysis
- 3.1 Neurovascular Devices Market Drivers
- 3.1.1 Increasing prevalence of neurological disorders leading to a surge in neurovascular devices
- 3.1.2 Increasing technological advancements in devices are escalating the market of neurovascular devices
- 3.1.3 Increase in product development activities among the key market players
- 3.2 Neurovascular Devices Market Restraints and Challenges
- 3.2.1 Incresaing product recalls
- 3.2.2 Stringent regulatory process for product approval
- 3.3 Neurovascular Devices Market Opportunity
- 3.3.1 Development of next-generation devices such as advanced flow-diverters, bioresorbable scaffolds, robotics-assisted intervention tools, among others
- 4. Impact Analysis
- 4.1 AI-Powered Innovations and Applications
- 4.2 U.S. Tariff Impact Analysis
- 5. Regulatory Analysis
- 5.1 The United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
- 6. Neurovascular Devices Market Porter’s Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Consumers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
- 7. Neurovascular Devices Market Assessment
- 7.1 By Product Type
- 7.1.1 Cerebral Embolization and Aneurysm Coiling Devices
- 7.1.1.1 Embolic Coils
- 7.1.1.2 Flow Diversion Devices
- 7.1.1.3 Liquid Embolic Agents
- 7.1.2 Cerebral Balloon Angioplasty and Stenting Systems
- 7.1.2.1 Carotid Artery Stents
- 7.1.2.2 Embolic Protection Systems
- 7.1.3 Neurothrombectomy Devices
- 7.1.3.1 Clot Retrievers
- 7.1.3.2 Suction Devices
- 7.1.3.3 Vascular Snare
- 7.1.4 Support Devices
- 7.1.4.1 Micro Catheters
- 7.1.4.2 Micro Guidewires
- 7.2 By Appliaction
- 7.2.1 Stroke
- 7.2.2 Cerebral Aneurysm
- 7.2.3 Carotid Artery Stenosis
- 7.2.4 Others
- 7.3 By End-Users
- 7.3.1 Hospitals
- 7.3.2 Ambulatory Surgical Centers
- 7.3.3 Others
- 7.4 By Geography
- 7.4.1 North America
- 7.4.1.1 United States Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.1.2 Canada Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.1.3 Mexico Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.2 Europe
- 7.4.2.1 France Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.2.2 Germany Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.2.3 United Kingdom Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.2.4 Italy Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.2.5 Spain Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.2.6 Rest of Europe Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.3 Asia-Pacific
- 7.4.3.1 China Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.3.2 Japan Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.3.3 India Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.3.4 Australia Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.3.5 South Korea Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.3.6 Rest of Asia-Pacific Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.4 Rest of the World (RoW)
- 7.4.4.1 Middle East Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.4.2 Africa Neurovascular Devices Market Size in USD million (2023-2034)
- 7.4.4.3 South America Neurovascular Devices Market Size In USD Million (2023-2034)
- 8. Competitive Landscape
- 9. Startup Funding & Investment Trends
- 10. Neurovascular Devices Market Company and Product Profiles
- 10.1 Johnson & Johnson Services Inc.
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Product Listing
- 10.1.5 Entropy
- 10.2 Medtronic
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Listing
- 10.2.5 Entropy
- 10.3 Stryker
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Listing
- 10.3.5 Entropy
- 10.4 Terumo Corporation
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Listing
- 10.4.5 Entropy
- 10.5 Penumbra, Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Listing
- 10.5.5 Entropy
- 10.6 Microport Scientific Corporation
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Listing
- 10.6.5 Entropy
- 10.7 Kaneka Corporation
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Listing
- 10.7.5 Entropy
- 10.8 Integer Holdings Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Listing
- 10.8.5 Entropy
- 10.9 phenox GmbH
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Listing
- 10.9.5 Entropy
- 10.10 Perflow Medical Ltd.
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Listing
- 10.10.5 Entropy
- 10.11 Balt
- 10.11.1 Company Overview
- 10.11.2 Company Snapshot
- 10.11.3 Financial Overview
- 10.11.4 Product Listing
- 10.11.5 Entropy
- 10.12 Rapid Medical
- 10.12.1 Company Overview
- 10.12.2 Company Snapshot
- 10.12.3 Financial Overview
- 10.12.4 Product Listing
- 10.12.5 Entropy
- 10.13 ASAHI INTECC CO., LTD.
- 10.13.1 Company Overview
- 10.13.2 Company Snapshot
- 10.13.3 Financial Overview
- 10.13.4 Product Listing
- 10.13.5 Entropy
- 10.14 Acandis GmbH
- 10.14.1 Company Overview
- 10.14.2 Company Snapshot
- 10.14.3 Financial Overview
- 10.14.4 Product Listing
- 10.14.5 Entropy
- 10.15 Cerus Endovascular Inc.
- 10.15.1 Company Overview
- 10.15.2 Company Snapshot
- 10.15.3 Financial Overview
- 10.15.4 Product Listing
- 10.15.5 Entropy
- 11. KOL Views
- 12. Project Approach
- 13. About DelveInsight
- 14. Disclaimer & Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
